Systematic practice-based interventions may help reduce the widespread use of antipsychotic polypharmacy

Author：  

Publisher： Adis International

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.28, Iss.4, 2012-04, pp. : 24-26

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antipsychotic Polypharmacy

By  

Current Pharmaceutical Design, Vol. 10, Iss. 18, 2004-07 ,pp. : 2231-2238

Bentham Science Publishers

Access to resources Recommend Favorite

Antipsychotic Polypharmacy: Still Dirty, But Hardly a Secret. A Systematic Review and Clinical Guide

By K. Tracy Derek   Sendt Kyra-Verena   S. Shergill Sukhwinder  

Current Psychopharmacology, Vol. 2, Iss. 2, 2013-05 ,pp. : 143-171

Bentham Science Publishers

Access to resources Recommend Favorite

Benefits and Risks of Antipsychotic Polypharmacy: An Evidence-Based Review of the Literature

By Tranulis Constantin  

Drug Safety, Vol. 31, Iss. 1, 2008-01 ,pp. : 7-20

Adis International

Access to resources Recommend Favorite

Safety and tolerability of antipsychotic polypharmacy

By Gallego Juan A   Nielsen Jimmi   De Hert Marc   Kane John M   Correll Christoph U  

Expert Opinion on Drug Safety, Vol. 11, Iss. 4, 2012-07 ,pp. : 527-542

Informa Healthcare

Access to resources Recommend Favorite

Antipsychotic polypharmacy in schizophrenia in Canada

By  

Inpharma, Vol. 1, Iss. 1296, 2001-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite